Jay R. Luly
Net Worth

Last updated:

What is Jay R. Luly net worth?

The estimated net worth of Dr. Jay R. Luly is at least $33,346,888 as of 6 Dec 2024. He owns shares worth $6,725,743 as insider, has earned $14,521,145 from insider trading and has received compensation worth at least $12,100,000 in Enanta Pharmaceuticals, Inc..

What is the salary of Jay R. Luly?

Dr. Jay R. Luly salary is $1,100,000 per year as Pres, Chief Executive Officer & Director in Enanta Pharmaceuticals, Inc..

How old is Jay R. Luly?

Dr. Jay R. Luly is 69 years old, born in 1956.

What stocks does Jay R. Luly currently own?

As insider, Dr. Jay R. Luly owns shares in one company:

Company Title Shares Price per share Total value
Enanta Pharmaceuticals, Inc. (ENTA) Pres, Chief Executive Officer & Director 801,638 $8.39 $6,725,743

What does Enanta Pharmaceuticals, Inc. do?

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

ENTA logo
ENTA
Enanta Pharmaceuticals, Inc.
$8.39

Jay R. Luly insider trading

Enanta Pharmaceuticals, Inc.

Dr. Jay R. Luly has made 22 insider trades between 2014-2024, according to the Form 4 filled with the SEC. Most recently he sold 5,142 units of ENTA stock worth $41,445 on 6 Dec 2024.

The largest trade he's ever made was exercising 251,119 units of ENTA stock on 10 Jan 2014. As of 6 Dec 2024 he still owns at least 801,638 units of ENTA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 5,142 $8.06 $41,445
Sale
Common Stock 7,230 $9.63 $69,625
Sale
Common Stock 15,649 $45.31 $709,056
Option
Stock Option (Right to Buy) 27,912 $14 $390,768
Option
Common Stock 27,912 $14 $390,768
Sale
Common Stock 1,566 $46.13 $72,240
Sale
Common Stock 10,697 $44.81 $479,333
Option
Common Stock 14,500 $27.58 $399,910
Option
Stock Option (Right to Buy) 14,500 $27.58 $399,910
Option
Common Stock 13,851 $14 $193,914
Option
Common Stock 16,149 $14.18 $228,993
Sale
Common Stock 13,603 $45.49 $618,800
Option
Stock Option (Right to Buy) 13,851 $14 $193,914
Option
Stock Option (Right to Buy) 16,149 $14.18 $228,993
Sale
Common Stock 8,597 $44.54 $382,910
Sale
Common Stock 7,800 $43.59 $340,002
Option
Common Stock 10,063 $11.77 $118,442
Option
Stock Option (right to buy) 10,063 $11.77 $118,442
Sale
Common Stock 4,516 $59.06 $266,697
Option
Restricted Stock Units 7,500 N/A N/A
Option
Common Stock 7,500 N/A N/A
Option
Common Stock 7,500 N/A N/A
Option
Restricted Stock Units 7,500 N/A N/A
Option
Stock Option (right to buy) 7,052 $14.18 $99,997
Option
Common Stock 7,052 $14.18 $99,997
Option
Common Stock 8,498 $11.77 $99,987
Option
Stock Option (right to buy) 8,498 $11.77 $99,987
Sale
Common Stock 32,023 $125.75 $4,027,020
Sale
Common Stock 2,977 $123.81 $368,567
Sale
Common Stock 10,968 $105.83 $1,160,743
Sale
Common Stock 14,032 $105.82 $1,484,908
Option
Common Stock 41,645 $2.97 $123,852
Option
Stock Option (right to buy) 41,645 $2.97 $123,852
Option
Stock Option (right to buy) 25,000 $2.97 $74,350
Option
Common Stock 25,000 $2.97 $74,350
Option
Stock Option (right to buy) 18,561 $2.54 $47,201
Option
Common Stock 18,561 $2.54 $47,201
Option
Stock Option (right to buy) 22,298 $1.29 $28,831
Option
Common Stock 68,700 $1.38 $94,737
Sale
Common Stock 15,000 $34.03 $510,390
Sale
Common Stock 15,000 $35.35 $530,295
Sale
Common Stock 15,000 $50.6 $759,060
Option
Stock Option (right to buy) 7,055 $0.73 $5,171
Option
Common Stock 7,055 $0.73 $5,171
Sale
Common Stock 15,000 $45.98 $689,625
Sale
Common Stock 15,000 $42.71 $640,680
Sale
Common Stock 15,000 $39.95 $599,250
Sale
Common Stock 10,000 $38.57 $385,650
Sale
Common Stock 5,800 $38.16 $221,340
Option
Stock Option (right to buy) 251,119 $0.73 $184,070
Option
Common Stock 251,119 $0.73 $184,070
Sale
Common Stock 5,800 $28.19 $163,508

Enanta Pharmaceuticals key executives

Enanta Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: